Abivertinib Recruiting Phase 1 Trials for B Cell Lymphoma (BCL) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03060850A Phase I Study of AC0010 in Patients With CLL/ SLL, MCL, DLBCL and Other NHL